|
|
 |
|
Viewing report
|
|
|
|
Bayer Schering Pharma AG: SWOT Analysis & Company Profile
Business Review, Sep 2010, Pages: 23
Synopsis
Business Review’s Bayer Schering Pharma AG contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company.
Summary
This SWOT Analysis company profile is a crucial resource for industry executives and anyone looking to quickly understand the key information concerning Bayer Schering Pharma AG’s business.
Business Review’s “Bayer Schering Pharma AG SWOT Analysis & Company Profile” reports utilize a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
Business Review strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about (Bayer Schering Pharma AG) for business intelligence requirements
- Studies and presents Bayer Schering Pharma AG’s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile contains business operations, the company history, major products and services, prospects, key competitors, structure and key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of the company.
- Obtain details and analysis of the market and competitors as well as internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
- Obtain yearly profitability figures
Key Highlights
Bayer Schering Pharma AG (Bayer Schering), formerly Schering AG, is a global research-based company, engages in the development, manufacture and marketing of pharmaceutical products. Its research and business activities are focused on the following areas including Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. Diagnostic Imaging includes magnetic resonance imaging (MRI) and X-ray contrast media. Specialty Medicine includes hemophilia therapies, drugs for solid-tumor therapy and for treating diseases of the central nervous system. General Medicine includes treatment in the areas of cardiovascular and metabolic diseases, thromboembolic diseases and pulmonary hypertension. The Company's products include Yasmin, Yasminelle, Betaferon, Betaseron, Kogenate, Adalat, Avalox, Cipro, Mirena, Levitra, among others. The Company’s production locations are in Europe, the United States, Latin America and Asia. Bayer Schering is headquartered in Berlin, Germany.
|
|
|
|
